Autres langues ProKidney Corp.

Actions

PROK

KYG7S53R1049

Cours en clôture Nasdaq Autres places de cotation 00:00:00 05/06/2024			Varia. 5j.	Varia. 1 janv.
3,68 ^USD	+14,64 %		+5,75 %	+106,74 %

28/05	Transcript : ProKidney Corp. - Special Call
10/05	La perte de ProKidney au premier trimestre reste inchangée par rapport à l'année précédente	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ProKidney to Participate in the Jefferies Global Healthcare Conference	29/05
ProKidney : Virtual KOL Presentation	28/05
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024	21/05
ProKidney Reports Business Updates and First Quarter 2024 Financial Results	13/05
ProKidney Q1 Loss Unchanged From Year Earlier	10/05
ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
ProKidney Reports Business Updates and First Quarter 2024 Financial Results	10/05
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	25/03
ProKidney Corp. Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	25/03
ProKidney Posts Wider 2023 Loss	22/03
ProKidney Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights	22/03
ProKidney to Participate in Jefferies Biotech on the Bay Summit	29/02
Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials Developments, Companies 2023 \| Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, Prokidney, and others.	05/12
ProKidney Corp. Announces Termination of Deepak Jain as Chief Operating Officer	30/11
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer	30/11
Prokidney Appoints Nikhil Pereira-Kamath as Chief Business Officer	30/11
ProKidney Files $500 Million Mixed Shelf	22/11
Prokidney Insider Sold Shares Worth $9,498,584, According to a Recent SEC Filing	21/11
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference	21/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ProKidney Corp.

Actions

PROK

KYG7S53R1049

Autres langues

Filtres